FDA Panel Backs Cholesterol Drug Trilipix

logo-trilipix

A Food and Drug Administration advisory panel concluded recently that Trilipix, the blockbuster cholesterol lowering drug from Abbott Labs, should continue to be marketed for use, despite a government study questioning the drug’s benefit. The panel further recommended that Trilipix be the focus of an additional study in order to see if the drug will [...]